Regenerative capacity in multiple sclerosis;La sclérose en plaques: Quelles possibilités de régénération?

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 3, 2008, Pages 495-506

  Lubetzki, Catherine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

(Index medicus); Demyelinating diseases drug therapy; Multiple sclerosis; Oligodendroglia; Signal transduction

Indexed keywords

HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; NERVE REGENERATION;

EID: 55249104139     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32807-9     Document Type: Article

References (32)

1. MARBURG O. - Die sogennante "akute multiple scklerose". Jahrbücher für Psychiatre und Neurologie. 1906, 27, 211-312.
2. PÉRIER O., GRÉGOIRE A. - Electron microscopic features of multiple sclerosis lesions. Brain. 1965, 88(5), 937-52.
3. PRINEAS J. W., CONNELL F. - Remyelination in multiple sclerosis. Ann. Neurol., 1979, 5(1), 22-31.
4. PRINEAS J. W., BARNARD R. O., KWON E. E., SHARER L. R., CHO E. S. - Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol., 1993, 33(2), 137-51.
5. RAINE C. S., WU E. - Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol., 1993, 52, 199-204.
6. SMITH K. J., BLAKEMORE W. F., MCD ONALD W. I. - The restoration of conduction by central remyelination. Brain. 1981, 104(2), 383-404.
7. NAIT-OUMESMAR B., PICARD-RIERA N., KERNINON C., DECKER L., SEILHEAN D., HÖGLINGER G. U., HIRSCH E. C., REYNOLDS R., BARON-VAN EVERCOOREN A. - Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proa Natl. Acad. Sci., U S A, 2001, 104(11), 4694-9.
8. DUBOIS-DALCQ M., FRENCH-CONSTANT C., FRANKLIN R. J. - Enhancing central nervous system remyelination in multiple sclerosis. Neuron., 2005, 48(1), 9-12. Review.
9. ALBERT M., ANTEL J., BRÜCK W., STADELMANN C. - Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 2007, 17(2), 39-38.
10. PATANI R., BALARATNAM M., VORA A., REYNOLDS R. - Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol., 2007, 33(3), 277-87.
11. PATRIKIOS P., STADELMANN C., KUTZELNIGG A., RAUSCHKA H., SCHMIDBAUER M., LAURSEN H., SORENSEN P. S., BRÜCK W., LUCCHINETTI C., LASSMANN H. - Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006, 129 (Pt 12), 3165-72.
12. COMAN I., AIGROT M. S., SEILHEAN D., REYNOLDS R., GIRAULT J. A., ZALC B., LUBETZKI C. - Nodal paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain, 2006, 129 (Pt 12), 3186-95.
13. WAXMAN S. G., CRANER M. J., BLACK J. A. - NA+ channel expression along axons in multiple sclerosis and its models. Trends Pharmacol. Sci., 2004 Nov, 25(11), 584-91.
14. ESHED Y., FEINBERG K., POLIAK S., SABANAY H., SARIG-NADIR O., SPIEGEL I., BERMINGHAM JR J. R., PELES E. - Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron, 2005, 47(2), 215-29.
15. ROTTER M. R., ZHAO C., VAN ROOIJEN N., FRANKLIN R. J. - Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis., 2005, 18(1), 166-75.
16. FOOTE A. K., BLAKEMORE W. F. - Inflammation stimulates remyelination in areas of chronic demyelination. Brain, 2005, 128 (Pt 3), 528-39.
17. WOLSWIJK G. - Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain. 2002, 125 (Pt 2), 338-49.
18. CHANG A., TOURTELLOTTE W. W., RUDICK R., TRAPP B. D.-Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. M ed., 2002, 346(3), 165-73.
19. JOHN G. R., SHANKAR S. L., SHAFIT- ZAGARDO B., MASSIMI A., LEE S. C., RAINE C. S., BROSNAN C. F. - Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. M ed., 2002, 8(10), 1115-21. Epub 2002 Sep. 23.
20. JURYNCZYK M., JUREWICZ A., BIELECKI B., RAINE C. S., SELMAJ K. - Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of Notch signaling. J. Neurol. Sci., 2007 Oct. 17, Epub ahead of print.
21. STIDWORTHY MF, GENOUD S, LI WW, LEONE DP, MANTEI N, SUTER U, FRANKLIN RJ. - Notchl and Jaggedl are expressed after CNS demyelination, but are not a major ratedetermining factor during remyelination. Brain. 2004, 127 (Pt 9): 1928-41.
22. MI S, MILLER RH, LEE X, SCOTT ML, SHULAG-MORSKAYA S, SHAO Z, CHANG J, THILL G, LEVESQUE M, ZHANG M, HESSION C, SAH D, TRAPP B, HE Z, JUNG V, MCCOY JM, PEPINSKY RB. - LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005, 8 (6): 745-51.
23. MI S, HU B, HAHM K, LUO Y, KAM HUI ES, YUAN Q, WONG WM, WANG L, SU H, CHU TH, GUO J, ZHANG W, SO KF, PEPINSKY B, SHAO Z, GZAFF C, GARBER E, JUNG V, WU EX, WU W. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med. 2007, 13(10), 1228-33. Epub 2007 Sep. 30.
24. CHARLES P., HERNANDEZ M. P., STANKOFF B., AIGROT M. S., COLIN C., ROUGON G., ZALC B., LUBETZKI C. - Negative regulation of central nervous system myelination by polysialylatedneural cell adhesion molecule. Proc Natle Acad. Sci., U S A. 2000, 97(13), 7585-90.
25. CHARLES P., REYNOLDS R., SEILHEAN D., ROUGON G., AIGROT M. S., NIEZGODA A., ZALC B., LUBETZKI C. - Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain. 2002, 125 (Pt 9), 1972-9.
26. DEMERENS C, STANKOFF B., LOGAK M., ANGLADE P., ALLINQUANT B., COURAUD F., ZALC B., LUBETZKI C. - Induction of myelination in the central nervous system by electrical activity. Proc Natle Acad. Sci., U S A., 1996, 93(18), 9887-92.
27. JOHNSON E. S., LUDWIN S. K. - The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol., 1981, 53(2), 93-8.
28. PENDERIS J., SHIEKDS S. A., FRANKLIN R. J. - Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain, 2003, 126 (Pt 6), 1382-91.
29. SASSKY N., DE CASTRO F., LE BRAS B., HEYDON K., QUÉRAUD-LESAUX F., BLOCH-GALLEGO E., CHÉDOTAL A., ZALC B., THOMAS J. L.-Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J. Neurosci., 2002, 22(14), 5992-6004.
30. WILLIAMS A., PIATON G., AIGROT M. S., BELHADI A., THÉAUDIN M., PETERMANN F., THOMAS J. L., ZALC B., LUERTZKI C. - Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain, 2007, 130 (Pt 10), 2554-65.
31. OMARI K. M., JOHN G., LANGO R., RAINE C. S. - Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia, 2006, 53(1), 24-31.
32. JARJOUR A. A., MANITT C., MOORE S. W., THOMPSON K. M., YUH S. J., KENNEDY T. E. - Netrin-1 is a chemorepellent for oligodendrocyte precursor cells in the embryonic spinal cord. J. Neurosci., 2003, 23(9), 3735-44.